Hematological Malignancies Market: Growing Prevalence of Leukemia to Support Demand for Therapeutics

Standard

Hematological Malignancies Market: Overview

This report provides in-depth region wise and country wise analysis of the hematological malignancies market. Stakeholders of this report include manufacturers of hematology cancer drugs, raw material suppliers, cancer drug processing companies, and new players planning to enter the market. It further presents qualitative and quantitative analysis of the global hematological malignancies market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information.

The opportunity in the worldwide market for hematological malignancies, which stood at US$27.4 bn in 2015, is likely to expand at a CAGR of 7.50% during the period from 2016 to 2024 and reach a value of US$51.9 bn by 2024.

Download Complete Healthcare Analytical Brochure:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4580

Quantitative analysis includes market share held by companies in 2015, market size, and forecast for the global hematological malignancies market in major countries globally such as the U.S., Canada, Germany, France, United Kingdom, Italy, Spain, Japan, China, Brazil, Mexico, South Africa and Saudi Arabia. Market revenue is provided in terms of US$ Mn from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 for all the segments, considering 2015 as the base year. The executive summary of the report provides a snapshot of the hematological malignancies with information on leading segments, country wise market information with respect to the market size, growth rate (CAGR %), and growth factors.

The market overview section, further, comprises impact factors such as drivers, restraints, and opportunities for the global hematological malignancies market. These factors would aid the stakeholders in establishing a strong foothold in the global hematological malignancies market. Furthermore, the market overview section comprises key industry events, product overview, market attractiveness analysis and emerging trend in the hematological malignancies market. The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and country wise to identify the most attractive market. Market share analysis is also provided in the competitive landscape section of the report for the year 2015 in terms of value (%)

Hematological Malignancies Market: Segmentation

The hematological malignancies market has been segmented as Disease condition type, therapy type, distribution channel and geography. Based on disease condition, the market has been segmented into leukemia, lymphoma and myeloma. Likewise, on basis of therapy the market has been categorized into chemotherapy, immunotherapy and targeted therapy. Hospital pharmacies, medical stores and e-commerce platform are included into the market by distribution channel.

Geographically, the hematological malignancies market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries comprising U.S. Canada, Germany, U.K., France, Italy, Spain, Japan, China, Brazil, Mexico, South Africa and Saudi Arabia have also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the hematological malignancies market in various regions has been provided in this section.

This report also includes various ups and downs about particular country or geography that has impacted the overall market globally. The report provides a detailed outline/blueprint of the hematological malignancies market globally that will assist new companies in establishing their presence and market players in expanding their market share in the market.

Companies mentioned in the report

The report concludes with the company profile section which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies and recent developments for market players. The major players that are profiled in the report include AbbVie, Inc., Bristol-Myers Squibb, Celgene Corporation, F. Hoffmann-La Roche Ltd., GlaxoSmithKline, and Novartis AG.

Browse Full Research Report on Hematological Malignancies Market:
http://www.transparencymarketresearch.com/hematological-malignancies-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Growth in Global Antibacterial Drugs Market Limited to 1.30% CAGR Owing to Patent Expiries

Standard

Transparency Market Research, in its latest report titled “Antibacterial Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023”, reveals that the global antibacterial drugs market is forecast to witness a rather slow growth from 2015 to 2023 owing to patent expiries of blockbuster drugs. Even though the market will register a meager CAGR of 1.30% during the forecast period, the value is anticipated to decline from US$43.9 bn in 2014 to US$38.9 bn in 2023.

Download Complete Healthcare Analytical Brochure:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1567

This report on antibacterial drugs market studies the current as well as future prospects of the market globally. The market for antibacterial drugs is segmented on the basis of major classes of drugs,namely,aminoglycosides,B-lactams, tetracyclines, sulfonamides, quinolones/fluoroquinolones, macrolides, phenicols and miscellaneous antibacterials. The market for each of these classes has been extensively analyzed on the basis of leading drug launch, patent expiry, drug efficacy, annual sales revenue and geography wise regulatory approval. The market size and forecast in terms of USD million for each of these classes has been provided for the period 2013 to 2023, considering 2013 and 2014 as the historical and base year respectively, while the market forecast has been provided for the period 2015 to 2023. The report on antibacterial drugs market also provides compounded annual growth rate (CAGR) for each market segment for the forecast period 2015 to 2023.

Geographically, the antibacterial drugs market has been categorized into five regions, namely, North America, Europe, Asia Pacific, Latin America and Rest of the World (ROW). Each of these geographies have been further segmented with respect to major countries; where North America is segmented in U.S. and Canada, Europe is segmented in U.K., Germany and rest of Europe, Asia Pacific is segmented in China, Japan and rest of Asia Pacific, and Latin America is segmented in Brazil and rest of Latin America. The report also comprises a section on pipeline analysis, which provides sales forecast for various drugs currently under phase III clinical trials and are expected to be launched during the forecast period. Forecast of seventeen pipeline drugs has been provided since their launch in the U.S., till 2023. Apart from the quantitative information, the report also provides details on various qualitative factors impacting the antibacterial market trends such as drug recalls, black box warning, changes in regulatory policies, drug patent expiry and subsequent launch of generics and others.

The research study also incorporates competitive scenario in the considered regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the global antibacterial drugs market, and future opportunities has been provided in the market overview section. This section of the report also provides detailed market attractiveness analysis for major geographies. The analysis considers factors such as level of competition, interference of government and regulatory agencies, available customer base and future potential. The global antibacterial drugs market report includes a chapter on competitive landscape which provides market share analysis by leading players in the antibacterial drugs market, in terms of percent share in the year 2014. The report also includes event impact analysis, which provides a holistic view of new drug approvals in the market. A list of recommendations has also been provided for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share.

The report also profiles major players in the antibacterial drugs market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Some of the major players profiled in this report include Allergan plc, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly & Co., Forest Laboratories, Inc., GlaxoSmithKline plc, Merck & Co., Inc. Novartis AG, Pfizer, Inc., and Sanofi.

Browse Full Research Report on Antibacterial Drugs Market:
http://www.transparencymarketresearch.com/antibacterial-drugs-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Global Allergy Diagnostics Market Attractiveness Analysis, by Product Type 2024

Standard

Allergy Diagnostics Market: Snapshot

The global allergy diagnostics market is poised to witness healthy growth during the next few years, driven primarily by the rising instances of allergies around the world and significant growth in diagnostic and treatment options for the same. The opportunity presented by the global market was pegged at US$1.3 bn in 2015 and is projected to be worth US$3.8 bn by 2024, expanding at a strong CAGR of 12.8% therein.

The market is characterized by extensive research efforts and technological advancements and manufacturers have been focused on conducting R&D activities to develop more effective diagnostic techniques, optimized allergens, and automated systems.

Request Sample pages of premium Research Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5147

Allergy Diagnostic Consumables Hold Dominant Share in 2015

By product, the consumables segment held the dominant share in the global allergy diagnostics market in 2015 and is likely to continue its lead throughout the forecast period. The low cost and high volume of consumables such as reagents and pipettes is the main factor responsible for the growth of the consumables segment.

Based on allergen type, inhaled allergens led the global allergy diagnostics market. Factors such as increased hygiene, especially in western countries, the lack of exposure to allergens at an early age, changing climatic conditions leading to strong and longer pollen seasons, the rise in tobacco smoking, and increased air pollution around the world are expected to drive the inhaled allergens segment during the forecast period. However, changing food habits and the increased consumption of packed and processed foods will lead to phenomenal growth in the food allergens segment by 2024.

Alarming Levels of Asthma and Inhaled Allergies Driving North America and Europe Market

North America led the global allergy diagnostics market with a share of more than 40% in 2015. According to the American Academy of Allergy Asthma and Immunology (AAAAI), approximately 26 million people in the U.S. suffered from allergic rhinitis in 2015, while around 15 million suffered from food allergies the same year. The lack of exposure to allergens in the early ages owing to increased hygiene levels in developed countries has led to the rising prevalence of inhaled allergies in the country. In addition to this, longer and stronger pollen seasons, technological advances in the field of allergy diagnostics, high per capita healthcare expenditure, and the increasing demand for better healthcare facilities are expected to drive the allergy diagnostics market in North America.

Europe is also a prominent market for allergy diagnostics in terms of revenue. According to the Allergy Organization of U.K., an estimated 150 million people in Europe suffered from allergies in 2015, of which, around 17 mn were diagnosed with food allergies. In the U.K. alone, approximately 5.4 million people were suffering from asthma in 2015. This growing prevalence of various types of allergies is expected to boost the demand for allergy diagnostics in the region.

The market in Asia Pacific is likely to expand at a phenomenal CAGR during the course of the forecast period. According to the Indian Council of Medical Research (IMCR), in 2014, around 17 million people in India suffered from asthma. Food allergies are the most prevalent form of allergies in Asia Pacific. According to the World Bank, around 84 million people in Asia Pacific suffered from food allergies in 2011. This will provide the allergy diagnostics market significant impetus during the forecast period.

Key players in the allergy diagnostics market include Thermo Fischer Scientific, Inc., Quest Diagnostics, Inc., BioMerieux SA, Stallergenes Greer, Omega Diagnostics Group Plc, Siemens Healthineers, and HAL Allergy Group.

Browse Full Research Report on Allergy Diagnostics Market:
http://www.transparencymarketresearch.com/allergy-diagnostics-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/